Published Work

Medicines, the NHS and Europe : balancing the public's interest

Público Deposited
Translation missing: pt-BR.dog_biscuits.fields.isbn
  • 1870607201
Translation missing: pt-BR.dog_biscuits.fields.creator
Translation missing: pt-BR.dog_biscuits.fields.place_of_publication
  • London
Translation missing: pt-BR.dog_biscuits.fields.publisher
  • King's Fund Institute
Translation missing: pt-BR.dog_biscuits.fields.date_published
  • 1990
Translation missing: pt-BR.dog_biscuits.fields.volume_number
  • 11
Translation missing: pt-BR.dog_biscuits.fields.pagination
  • 24
Translation missing: pt-BR.dog_biscuits.fields.series
  • KFI briefing paper
Translation missing: pt-BR.dog_biscuits.fields.abstract
  • The report examines the likely impact of the indicative drug budgets for family doctors and the government's general practice fund holding initiative in Britain. The authors believe that the new arrangements will sharpen price competition in the UK medicines market, and welcome this. The study also reports on recent European proposals to extend 'on-the-market' pharmaceutical patent terms in Europe to 16 years. The report looks to the future of medicines-spending and the role of pharmacists.
Translation missing: pt-BR.dog_biscuits.fields.note
  • Pagination: 24p.
Translation missing: pt-BR.dog_biscuits.fields.subject
Translation missing: pt-BR.dog_biscuits.fields.resource_type
Translation missing: pt-BR.dog_biscuits.fields.rights_statement
Translation missing: pt-BR.dog_biscuits.fields.biblionumber
License

Relações

Itens